Reduced Fermentation Time Icon
Enhanced Glycosyltransferase activity leads to a faster Scleroglucan production rate, lowering batch time and cost.
Scleroglucan is a neutral, non-ionic exopolysaccharide highly valued as a Thickeners/EOR Enhanced Oil Recovery agent for its high viscosity, stability across extreme temperatures, and shear-thinning behavior. The traditional supply chain faces key limitations: Traditional fungal fermentation Sclerotium rolfsii is slow and prone to contamination, leading to extended batch times and high risk of culture loss. This hampers large-scale, cost-effective production.
CD Biosynsis offers a combined approach focusing on bioprocess optimization and genetic enhancement: Optimization: Optimize fungal fermentation conditions medium composition, pH to maximize polysaccharide yield and minimize side product formation. This immediately enhances current productivity. Crucially, we use Genetic Modification: Enhance the Glycosyltransferase activity involved in Scleroglucan synthesis. This biological modification increases the intrinsic rate of polymer formation, dramatically improving the overall production efficiency and titer.
Get a QuoteThe industrial production of Scleroglucan faces these primary challenges:
A successful platform requires both acceleration of the biosynthesis rate and improved control over the fermentation process.
CD Biosynsis utilizes genetic and bioprocess optimization to enhance Scleroglucan production:
Glycosyltransferase Enhancement
We enhance the expression and activity of key Glycosyltransferases involved in forming the Scleroglucan polymer backbone and side chains, directly increasing the synthesis rate.
Bioprocess Parameter Optimization
We perform comprehensive DoE Design of Experiments optimization on medium composition e.g. carbon source and pH control to maximize Scleroglucan yield and titer.
Contamination Tolerance
We use genetic or process engineering strategies e.g. non-conventional media or strain modification to enhance the Sclerotium rolfsii strain's resistance to common bacterial contaminants.
Precursor Flux Analysis
We use metabolic flux analysis to identify and relieve bottlenecks in the nucleotide sugar precursor supply for Glycosyltransferase activity, ensuring a continuous flow of building blocks.
This integrated optimization dramatically reduces fermentation time and increases the yield of high-quality Scleroglucan.
Our Scleroglucan engineering service is dedicated to pursuing the following production goals:
Reduced Fermentation Time Icon
Enhanced Glycosyltransferase activity leads to a faster Scleroglucan production rate, lowering batch time and cost.
Maximize Yield and Titer Icon
Optimized medium and process parameters ensure the highest possible polysaccharide concentration from the fermentation.
Improved Process Reliability Icon
Reduced fermentation time and enhanced contamination tolerance reduce the risk of batch loss.
Consistent Product Quality Icon
Precise control over fermentation conditions minimizes side product formation for cleaner output.
Optimal Rheological Performance Icon
Process optimization ensures the final Scleroglucan has the desired high viscosity and stability required for EOR applications.
We deliver a faster, more reliable, and higher-yield platform for Scleroglucan production.
Our Scleroglucan engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a high-titer, reliable Scleroglucan supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is fungal fermentation Sclerotium rolfsii so slow?
Sclerotium rolfsii is a filamentous fungus that typically exhibits a slower growth rate compared to bacteria or yeast, and it dedicates a significant part of its metabolism to biomass formation mycelia before starting high-rate exopolysaccharide secretion. The complex morphology and pellet formation also contribute to mass transfer limitations oxygen starvation in the center of pellets, slowing the overall process.
How does enhancing Glycosyltransferase activity accelerate Scleroglucan synthesis?
Glycosyltransferases are the enzymes that link the sugar units e.g. glucose into the long polysaccharide chain. If their activity is the rate-limiting step in Scleroglucan formation, increasing their expression or catalytic efficiency directly increases the speed at which the polymer is assembled, leading to a higher yield in the same or shorter time.
How do you minimize side product formation?
Side product formation e.g. unwanted proteins or organic acids is minimized by precisely controlling the fermentation environment pH and nutrient availability. We design the medium and feeding strategy to favor polysaccharide synthesis over other metabolic routes, ensuring a cleaner broth and easier downstream purification.
What makes Scleroglucan ideal for Enhanced Oil Recovery EOR?
Scleroglucan is neutral and exceptionally stable. It maintains high viscosity across a wide range of temperatures up to 130}°C$, salinities, and pH levels. Its shear-thinning property allows it to be pumped easily at high shear rates through pipelines, but it recovers viscosity rapidly in the low-shear conditions of the reservoir, making it an ideal mobility control agent.
What is the estimated project timeline?
A comprehensive project involving Glycosyltransferase engineering, strain enhancement, and bioprocess optimization typically requires 28-36 weeks for final strain delivery and validated high-yield fermentation protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.